olaparib
merck,astrazeneca
['olaparib']
kristina fanucci presents phase 2 trial of olaparib in recurrent idh-mutant glioma now until 11am at board 373! #oncology #asco22 
Heme/Onc #Oncology fellow at @YaleHemOnc @YaleCancer. Interested in #Melanoma #MELSM #LungCancer #LCSM #ClinicalTrials #TranslationalMedicine. ??????????